Sage Journals: Discover world-class research

Abstract

Keywords

nintedanib inflammatory bowel disease mimic nintedanib-associated colitis lung cancer therapy inflammatory bowel disease

Get full access to this article

View all access options for this article.

References

Flaherty

Wells

Cottin

, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019;381(18):1718‐1727.

Tang

Abu-Sbeih

, et al. Gastrointestinal injury related to antiangiogenesis cancer therapy. Clin Colorectal Cancer. 2020;19(3):e117‐e123.

Pai

Brown

, et al. The significance of histological activity measurements in immune checkpoint inhibitor colitis. Aliment Pharmacol Ther. 2021;53(1):150‐159.

Kővári

Báthori

Friedman

Lauwers

. Histologic diagnosis of inflammatory bowel diseases. Adv Anat Pathol. 2022;29(1):48‐61.

Oda

Matsunaga

Sennari

Yatera

. Colitis associated with nintedanib therapy for idiopathic pulmonary fibrosis (IPF). Intern Med. 2017;56(10):1267‐1268.

Amini

Koury

Chahla

. Nintedanib-induced colitis treated effectively with budesonide. Cureus. 2020;12(7):e9489.

Ali

Barash

Mohammed

Ramalingam

. Severe pancolitis: a rare adverse effect of nintedanib. Chest. 2018;154(4):446A.

Chandler

. Nintedanib and ischemic colitis: signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health-care databases. Pharmacoepidemiol Drug Saf. 2020;29(8):951‐957.

Peterson

Haberstroh

Teslova

. Nintedanib-induced ischemic colitis masquerading as inflammatory bowel disease. Am J Gastroenterol. 2021;116(1):S805.

Inflammatory Bowel Disease-Mimicking Colitis Associated With Nintedanib-Based Therapy in a Lung Cancer Patient

Abstract

Keywords

Get full access to this article

References